foxo4-dri senolytic study The disordered p53 transactivation domain is the target of FOXO4 and the compound Tablets Type:Without DAC 10mg*10 vials bpc-157 thymosin beta-4 combination
Pay in 4 interest-free payments of $6.27 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 20 - Sep 25